Please assess the completion status of the following clinical trial:

Trial Title: Reconstruction of Monocytic Immunocompetence by Granulocyte-macrophage-colony Stimulating Factor (GM-CSF) in Patients With Severe Sepsis and Septic Shock

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Severe sepsis or septic shock,~* Presence of infection,~* 2 SIRS criteria,~* Acute organ dysfunction,~* Immunoparalysis,~* Informed consent~Exclusion Criteria:~* Pregnancy,~* Known allergies to study medication or components,~* Moribound patient,~* Autoimmune disease,~* HIV-infection,~* Acute MI or pulmonary embolism,~* Cpr during last 72 hours,~* Patients who participate in a different clinical study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Verum (Type: EXPERIMENTAL): GM-CSF therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).